We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
120 hedge funds and large institutions have $319M invested in Puma Biotechnology in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
62% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $696K
21% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 39
15% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 13
2% more funds holding
Funds holding: 118 → 120 (+2)
4.84% less ownership
Funds ownership: 90.97% → 86.13% (-4.8%)
10% less capital invested
Capital invested by funds: $356M → $319M (-$36.6M)
Holders
120
Holders Change
+2
Holders Change %
+1.69%
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
47
Reduced
39
Closed
13
Calls
$1.13M
Puts
$696K
Net Calls
+$430K
Net Calls Change
+$273K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.83M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$1.72M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.52M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.34M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$1.3M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$8.04M |
| 2 |
FAM
Fred Alger Management
New York
|
-$6.49M |
| 3 |
Goldman Sachs
New York
|
-$4.45M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$3.35M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.35M |
